FDA approved drug offers new hope to MS patients
Just two weeks after a new drug was approved for use by the FDA to treat Multiple Sclerosis, the first patient is getting an infusion.
Cheryl Conner finds out what the new drug is expected to do.
Bob King has lived with multiple sclerosis for 38 years and tried different treatments, including a stem cell transplant in Panama.
Now he sees Dr. Heidi Crayton at the Multiple Sclerosis Center of Greater Washington for treatment.
Bob says, "It's quite a bit worse now than it was then."
But now there is a new drug approved by the FDA just two weeks ago to address his progressive form of MS.
It's called Ocrevus.
Bob said "…and what I'm hoping for now is with this drug it will like halt it where it is."
Dr. Crayton says it's the first treatment in the D.C. area. "The goal is always to try to make people as flat as possible and unchanged as possible," said Dr. Crayton.
Because right now, there's no drug to turn back the clock, King realizes he may not get to travel to Europe again.
He calls his last trip to the Ukraine three years ago his “last hoo rah.”
He made that trip using just a cane, instead of a walker.
King’s insurance is paying for the treatment, but without coverage, the treatment is $65,000 a year.
Bob King says he hopes a positive attitude will mix well with the new drug.